TPX2 and hepatocellular carcinoma: The results showed that, overexpression of TPX2 in MHCC97-L cells accelerated the metabolism and clearance of Sorafenib in the subcutaneous tumour tissues formed by HCC cells (the t1/2 values: 29.70 [21.38–36.75] for control group v.s.